Clinical Course Of Disease In Participants With FA-CM

Part of paid clinical trials in La Jolla, California.

Sponsor
Lexeo Therapeutics
Study ID
NCT06865482
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Key Dates

Start date
Sep 30, 2025
Status verified
Jun 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
65 participants (estimated)

Arms

  • Arm: Cohort 1: Participants ≥16 years of age with FA-CM
    Participants ≥16 years of age with FA-CM
  • Arm: Cohort 2: Participants ≥6 to <16 years of age with FA-CM
    Participants ≥6 to \<16 years of age with FA-CM

Primary Outcome Measure

Characterize cardiac disease presentation and progression among participants [ Time Frame: 26 weeks ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
University of California San DiegoLa JollaCalifornia92037
University of South FloridaTampaFlorida33612
[email protected]
Indiana University - Riley Children's HealthIndianapolisIndiana46202
Boston Children's HospitalBostonMassachusetts02115
Mayo ClinicRochesterMinnesota55905
Washington University School of Medicine in St. LouisSt LouisMissouri63110
Cincinnati Children's HospitalCincinnatiOhio45229
[email protected]
Oregon Health & Science UniversityPortlandOregon97239

Find similar trials in La Jolla, CA

By research site
University of California San Diego· La Jolla, CAUniversity of South Florida· Tampa, FLIndiana University - Riley Children's Health· Indianapolis, INBoston Children's Hospital· Boston, MAMayo Clinic· Rochester, MNWashington University School of Medicine in St. Louis· St Louis, MO

Related Studies